Collegium Pharmaceutical, Inc. (COLL) Social Stream
COLLEGIUM PHARMACEUTICAL INC (COLL) Price Targets From Analysts
Use the tables below to see what analysts covering COLLEGIUM PHARMACEUTICAL INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-05 | 8 | $36 | $8 | $24.857 | $25.49 | -2.48% |
| 2021-11-28 | 8 | $36 | $8 | $25.142 | $25.49 | -1.37% |
| 2022-01-11 | 6 | $36 | $8 | $25.142 | $25.49 | -1.37% |
| 2022-01-21 | 6 | $36 | $8 | $25 | $25.49 | -1.92% |
| 2022-02-15 | 7 | $36 | $8 | $25.5 | $25.49 | 0.04% |
| 2022-02-25 | 7 | $42 | $8 | $26.5 | $25.49 | 3.96% |
| 2022-04-06 | 7 | $42 | $8 | $27 | $25.49 | 5.92% |
| 2022-04-28 | 7 | $40 | $8 | $26.666 | $25.49 | 4.61% |
| 2022-05-10 | 7 | $37 | $8 | $26.166 | $25.49 | 2.65% |
| 2022-07-18 | 8 | $37 | $8 | $27.714 | $25.49 | 8.72% |
| 2022-08-05 | 6 | $37 | $8 | $27.333 | $25.49 | 7.23% |
| 2022-11-30 | 6 | $35 | $8 | $25.8 | $25.49 | 1.22% |
| 2023-01-06 | 6 | $40 | $8 | $30.2 | $25.49 | 18.48% |
| 2023-01-09 | 6 | $35 | $8 | $27.4 | $25.49 | 7.49% |
| 2023-02-08 | 6 | $35 | $26 | $32.25 | $25.49 | 26.52% |
| 2023-02-12 | 6 | $36 | $26 | $32.5 | $25.49 | 27.5% |
| 2023-02-16 | 6 | $40 | $33 | $36 | $25.49 | 41.23% |
| 2023-04-19 | 6 | $40 | $33 | $36.25 | $25.49 | 42.21% |
| 2023-04-25 | 7 | $40 | $33 | $35.75 | $25.49 | 40.25% |
| 2023-05-09 | 6 | $40 | $30 | $35 | $25.49 | 37.31% |
| 2023-07-04 | 7 | $40 | $30 | $34.6 | $25.49 | 35.74% |
| 2023-07-25 | 6 | $35 | $30 | $33.25 | $25.49 | 30.44% |
| 2023-08-08 | 6 | $37 | $30 | $33.75 | $25.49 | 32.4% |
| 2023-08-25 | 6 | $37 | $30 | $34 | $25.49 | 33.39% |
| 2023-11-10 | 6 | $37 | $30 | $33.5 | $25.49 | 31.42% |
The Trend in the Analyst Price Target
COLL's average price target has moved up $3.93 over the prior 31 months.
COLL reports an average of 41% for its upside potential over the past 49 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-05 | 6 | 35 | 8 | 27.40 | 28.04 | -2.28% |
| 2023-01-06 | 6 | 40 | 8 | 30.20 | 28.65 | 5.41% |
| 2023-02-16 | 6 | 40 | 33 | 36.00 | 26.55 | 35.59% |
| 2023-07-04 | 7 | 35 | 30 | 33.25 | 21.43 | 55.16% |
| 2023-11-10 | 6 | 37 | 30 | 33.50 | 24.48 | 36.85% |
COLL Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.5 | 4 | 1 | 1 | 0 | 0 | 6 |
The Trend in the Broker Recommendations
Over the past 16 months, COLL's average broker recommendation rating improved by 0.12.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for COLL as an investment opportunity.
- COLLEGIUM PHARMACEUTICAL INC's variance in analysts' estimates is lower than -1775.11% of all US stocks.
- In terms of how COLLEGIUM PHARMACEUTICAL INC fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is greater than 393.35% of that group.
- In terms of how COLLEGIUM PHARMACEUTICAL INC fares relative to stocks in the small market cap category, note that its number of analysts covering the stock is greater than 2300.46% of that group.
- COLL has a higher average analyst price target than 2167.78% of stocks in the small market cap category.
Stocks similar to COLLEGIUM PHARMACEUTICAL INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are RDHL, KMDA, and IMMP.
View All Top Stocks by Price Target
What is the outlook for COLL? Use POWR Ratings for clearer insight into price direction.